The center is designed to bring rigorous scientific scrutiny to drugs that have increasingly entered public conversations about mental health care. The Center for Psychedelics Research and Treatment is anchored by the Feinstein Family Human Neuropsychopharmacology Laboratory, a state-of-the-art clinical facility built at Zucker Hillside Hospital in Glen Oaks, 75-59 263rd St. Initial research projects include a clinical trial evaluating psilocybin for the treatment of social anxiety disorder using active and inactive controls. Officials said that within five years, the center plans to complete its initial research, move into larger studies supported by federal funding, and launch a clinical treatment program. Donations to support the Center for Psychedelics Research and Treatment can be made through Northwell Health.